Further Reading

References:

  • Baldisseri M. Impaired healthcare professional. Critical Care Medicine 2007; 35 (Suppl 2): S106-16.
  • Berge K, Seppala MD, Schipper AM. Chemical Dependency and the Physician. Mayo Clinic Proceedings 2009; 84: 625-31.
  • Domino KB et al. Risk Factors for Relapse in Health Care Professionals with Substance Use Disorders. JAMA 2005; 293:1453-60.
  • Working group on the misuse of alcohol and drugs by doctors. London: British Medical Association, 1998.
  • Skipper GE, Campbell MD, DuPont RL. Anesthesiologists with Substance Use Disorders; A 5-Yea Outcome Study from 16 State Physician Health Programs. Anesthesia & Analgesia 2009; 109: 891- 96.
  • Hughes PH, Storr CL.et al. Physician substance use by medical specialty. J Addict Dis 1999; 18(2): 23–37.
  • Gallegos KV, Browne CH, Veit FW, Talbott GD. Addiction in anesthesiologists: drug access and patterns of substance abuse. QRB Qual Rev Bull. 1988 Apr;14(4):116-22
  • Dobson B. Head of Case Review GMC 2010; (personal communication).
  • Talbott GD, Gallegos KV, Wilson PO, Porter TL. The Medical Association of Georgia’s Impaired Physicians Program Review of the First 1000 Physicians: Analysis of Specialty. Journal of the American Medical Association 1987; 257: 2927-30.
  • Gallegos KV, Lubin BH, Bowers C, Blevins JW, Talbott GD, Wilson PO. Relapse and recovery: Five to ten year follow-up study of chemically dependent physicians – the Georgia experience. Maryland Medical Journal 1992; 41: 315-9.
  • Lutsky I,Hopwood M, Abram SE, Cerletty JM, Hoffman RG, Kampine JP. Use of psychoactive substances in three medical specialties:anaesthesia, medicine and surgery Canadian Journal of Anaesthesia 1994; 41:561-7
  • Silverstein JH, Silva DA, Iberti TJ. Opioid addiction in Anesthesiology. Anesthesiology 1993; 79: 354-75.
  • Brewster JM, Kaufmann M. Characteristics and outcomes of doctors in a substance abuse monitoring programme in Canada: prospective descriptive study. British Medical Journal 2008; 337:a2098 (accessed 15.10.2009).
  • Foll BLe, Gallo A, Strat YLe, Lu L, Gorwood P. Genetics of dopamine receptors and drug addiction: a comprehensive review. Behavioural Pharmacology 2009; 20: 1-17.
  • Drgon T, D’Addario C, Uhl GR. Linkage disequilibrium, haplotype and association studies of a chromosome 4 GABA receptor gene cluster: Candidate gene variants for addictions. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2006; 141B: 854 – 860.
  • The Health and Social Care Information Centre. NHS Information Centre Statistics on Alcohol England 2009; 13-14.
  • The Health and Social Care Information Centre. NHS Information Centre: Statistics on Drug Misuse England 2007.
  • Mayall RM. The way I see it… Helping addicted doctors. BMJ September 30th 2006
  • Early P, Finver T. Addiction to Propofol: A Study of 22 Treatment Cases. J Addict Med 2013;00: 1–8. journals.lww.com/journaladdictionmedicine/Documents/ADM200274.pdf